4//SEC Filing
Benaim Ely 4
Accession 0001645113-23-000012
CIK 0001645113other
Filed
Jan 9, 7:00 PM ET
Accepted
Jan 10, 4:14 PM ET
Size
5.3 KB
Accession
0001645113-23-000012
Insider Transaction Report
Form 4
NovoCure LtdNVCR
Benaim Ely
Chief Medical Officer
Transactions
- Award
Ordinary Shares
2023-01-06$62.30/sh+98$6,106→ 28,770 total
Footnotes (2)
- [F1]The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of July 1, 2022 through December 30, 2022. This transaction is also exempt under Rule 16b-3(c).
- [F2]In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on July 1, 2022.
Documents
Issuer
NovoCure Ltd
CIK 0001645113
Entity typeother
Related Parties
1- filerCIK 0001632237
Filing Metadata
- Form type
- 4
- Filed
- Jan 9, 7:00 PM ET
- Accepted
- Jan 10, 4:14 PM ET
- Size
- 5.3 KB